RxDoctor Payments DataLook up a doctor →

Ryan Kaple, MD

Interventional Cardiology · Hackensack, NJNPI 1154580694

Payments from drug & device makers

$279,513in general payments, 2019–2025

Across 720 payments — averaging $388.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$236K
  • Medtronic$23K
  • Edwards Lifesciences$16K
  • Boston Scientific$1K
  • Ancora Heart, Inc.$1K
  • Abiomed$548
  • plus $2K from 20 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$279,513 in reported general payments places this provider in the 95th percentile of 166 interventional cardiology providers in New Jersey.

See all interventional cardiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$124,566
Medicare patients
190
Services billed
486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →